1020P MPT-0118 a clinical drug candidate to assess Treg reprogramming via MALT1 blockade
Keller, P., Mazo, I., Gao, Y., Reddy, V., Caballero, F., Stephens, B., Marvin, J.E., Fu, A., Sun, Y., Jenkins, R.W., von Andrian, U.H., Mempel, T.R.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article